Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant Ineligible”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03829371
What this trial is testing

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Who this might be right for
Multiple Myeloma
University of Turin, Italy 450
Testing effectiveness (Phase 2)Study completedNCT00682305
What this trial is testing

Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04451200
What this trial is testing

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

Who this might be right for
Acute LeukemiaMielodysplasic SyndromeMyeloproliferative Neoplasm
Institut Paoli-Calmettes 82
Testing effectiveness (Phase 2)Study completedNCT04939844
What this trial is testing

REST - Replacing Steroids in the Transplant Ineligble

Who this might be right for
Multiple Myeloma
Oslo University Hospital 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04717700
What this trial is testing

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Ida Bruun Kristensen 50
Testing effectiveness (Phase 2)Looking for participantsNCT04792489
What this trial is testing

DALY II USA/ MB-CART2019.1 for DLBCL

Who this might be right for
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+6 more
Miltenyi Biomedicine GmbH 315
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07247097
What this trial is testing

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple MyelomaTransplant Ineligible+1 more
Massachusetts General Hospital 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT04531046
What this trial is testing

Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation

Who this might be right for
B-Cell Lymphoma RefractoryB-cell Lymphoma Recurrent
The Lymphoma Academic Research Organisation 62
Large-scale testing (Phase 3)Looking for participantsNCT06932562
What this trial is testing

Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07507760
What this trial is testing

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
PETHEMA Foundation 50
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT03242460
What this trial is testing

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed and/or refractorY Multiple Myeloma
Kosin University Gospel Hospital 55
Large-scale testing (Phase 3)Study completedNCT01078454
What this trial is testing

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
National Cancer Institute (NCI) 11
Not applicableNo Longer AvailableNCT03639844
What this trial is testing

BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study

Who this might be right for
Hurler SyndromeInherited Metabolic DisorderLysosomal Storage Disorder+2 more
Bellicum Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00992134
What this trial is testing

Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
St. Bortolo Hospital 41
Not applicableNot Yet RecruitingNCT07070960
What this trial is testing

Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

Who this might be right for
Multiple MyelomaNewly Diagnosed
Xuzhou Medical University 35
Testing effectiveness (Phase 2)Looking for participantsNCT05979363
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia

Who this might be right for
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04808037
What this trial is testing

Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hellenic Society of Hematology 66
Testing effectiveness (Phase 2)Looking for participantsNCT05245656
What this trial is testing

A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Kim, Seok Jin 90
Large-scale testing (Phase 3)Active Not RecruitingNCT04096066
What this trial is testing

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

Who this might be right for
Multiple MyelomaNew Diagnosis Tumor
Fondazione EMN Italy Onlus 84
Next Page